Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,646 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and disposition of dalcetrapib in rats and monkeys.
Takubo H, Ishikawa T, Kuhlmann O, Nemoto H, Noguchi T, Nanayama T, Komura H, Kogayu M. Takubo H, et al. Among authors: ishikawa t. Xenobiotica. 2014 Dec;44(12):1117-26. doi: 10.3109/00498254.2014.932471. Epub 2014 Jun 23. Xenobiotica. 2014. PMID: 24954481 Clinical Trial.
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry.
Heinig K, Bucheli F, Kuhlmann O, Zell M, Pähler A, Zwanziger E, Gross G, Tardio J, Ishikawa T, Yamashita T. Heinig K, et al. Among authors: ishikawa t. J Pharm Biomed Anal. 2012 Jul;66:314-24. doi: 10.1016/j.jpba.2012.03.056. Epub 2012 Apr 6. J Pharm Biomed Anal. 2012. PMID: 22541249
A Mass Balance Study of 14 C-Labeled JTZ-951 (Enarodustat), a Novel Orally Available Erythropoiesis-Stimulating Agent, in Patients With End-Stage Renal Disease on Hemodialysis.
Pai SM, Connaire J, Yamada H, Enya S, Gerhardt B, Maekawa M, Tanaka H, Koretomo R, Ishikawa T. Pai SM, et al. Among authors: ishikawa t. Clin Pharmacol Drug Dev. 2020 Aug;9(6):728-741. doi: 10.1002/cpdd.752. Epub 2019 Dec 25. Clin Pharmacol Drug Dev. 2020. PMID: 31876104 Clinical Trial.
Effects of a Nutritional Protein-Rich Drink on the Pharmacokinetics of Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide, and Tenofovir Compared With a Standard Meal in Healthy Japanese Male Subjects.
Yamada H, Ikushima I, Nemoto T, Ishikawa T, Ninomiya N, Irie S. Yamada H, et al. Among authors: ishikawa t. Clin Pharmacol Drug Dev. 2018 Feb;7(2):132-142. doi: 10.1002/cpdd.365. Epub 2017 Jun 5. Clin Pharmacol Drug Dev. 2018. PMID: 28581645 Clinical Trial.
Effects of a protein-rich drink or a standard meal on the pharmacokinetics of elvitegravir, cobicistat, emtricitabine and tenofovir in healthy Japanese male subjects: a randomized, three-way crossover study.
Shiomi M, Matsuki S, Ikeda A, Ishikawa T, Nishino N, Kimura M, Irie S. Shiomi M, et al. Among authors: ishikawa t. J Clin Pharmacol. 2014 Jun;54(6):640-8. doi: 10.1002/jcph.283. Epub 2014 Mar 18. J Clin Pharmacol. 2014. PMID: 24615728 Free PMC article. Clinical Trial.
Pharmacokinetic and bioequivalence evaluation of single-tablet and separate-tablet regimens for once-daily cobicistat-boosted elvitegravir in healthy Japanese male subjects: A randomized, two-way crossover study.
Shiomi M, Matsuki S, Ikeda A, Ishikawa T, Nishino N, Kimura M, Kumagai Y, Irie S. Shiomi M, et al. Among authors: ishikawa t. Clin Pharmacol Drug Dev. 2015 May-Jun;4(3):218-25. doi: 10.1002/cpdd.164. Epub 2014 Oct 27. Clin Pharmacol Drug Dev. 2015. PMID: 27140802 Clinical Trial.
Efficacy and safety of tumor necrosis factor inhibitors for systemic juvenile idiopathic arthritis: a systematic review.
Ishikawa T, Nishimura K, Okamoto N, Akamine K, Inoue N, Irabu H, Kato K, Keino H, Kojima M, Kubo H, Maruyama K, Mizuta M, Shabana K, Shimizu M, Sugita Y, Takakuwa Y, Takanashi S, Takase H, Umebayashi H, Umezawa N, Yamanishi S, Yamazaki K, Yashiro M, Yasumi T, Mori M. Ishikawa T, et al. Mod Rheumatol. 2024 May 25:roae050. doi: 10.1093/mr/roae050. Online ahead of print. Mod Rheumatol. 2024. PMID: 38795057
7,646 results